MiR‐22 has also been found to target many genes encoding cancer‐associated proteins, including the TET2 tumor suppressor, HDAC6, ERBB3, CDC25C, EVI‐1, and P21 [21, 22, 23, 24], which play different roles in different types of cancer. This evidence concerns the gene HDAC6 and neoplasm.